Search - tctmd.com

Displaying 681 - 700 of 807

Sort: Relevancy | Date

Presentation TVT 2013

Pharmacotherapy Alternatives During and After TAVR: Is There an Optimal Regimen?

Presenter: Corrado Tamburino

June 12, 2013

Presentation TVT 2013

Pathoanatomic Findings from Filtered Debris After TAVR

Presenter: Nicolas van Mieghem

June 12, 2013

Presentation

Comparison of Final Infarct Volumes with Endovascular Therapy vs. IV Thrombolysis for Acute Intracranial Large-Vessel Occlusions

Presenter: S. Rangaraju

May 17, 2013

Presentation

PROTECT AF: The Mortality Effects of LAA Closure vs. Warfarin for Stroke Prophylaxis in A-fib

Presenter: Vivek Y. Reddy

May 14, 2013

Presentation

Angioplasty Following Carotid Stent Deployment Reduces the Risk of Restenosis and May or May Not Increase the Risk of Procedure-Related Stroke

Presenter: Mahmoud B. Malas

May 09, 2013

Presentation

Stroke After Primary PCI in Patients with STEMI

Presenter: J.T. Guptill

May 02, 2013

Presentation

PFO, Subclinical Cerebrovascular Disease and Ischemic Stroke in a Population-based Cohort

Presenter: Marco R. Di Tullio

April 30, 2013

Presentation

Rescue Treatment of Thromboembolic Complications During Endovascular Treatment of Cerebral Aneurysms

Presenter: Waleed Brinjikji

April 26, 2013

Presentation

Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation

Presenter: A.R. Harrington

April 05, 2013

Presentation ECHO 2013

Advanced TEE: Clinical Decision Making in Cryptogenic Stroke and Atrial Fibrillation

Presenter: Marco R. Di Tullio

April 04, 2013

Presentation

RESPECT: Closure of Patent Foramen Ovale (PFO) vs. Medical Therapy After Cryptogenic Stroke

Presenter: John D. Carroll

March 20, 2013

Presentation ACC 2013

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Presenter: David R. Holmes, Jr.

March 08, 2013

Presentation

Endovascular Stroke Therapy: Tirofiban Is Associated with Risk of Fatal Intracerebral Hemorrhage and Poor Outcome

Presenter: L. Kellert

March 07, 2013

Presentation

Quality-of-Life Assessment in the Randomized PROTECT AF Trial of Patients at Risk for Stroke with Nonvalvular A-fib

Presenter: 147572|Oluseun Alli

February 27, 2013

Presentation

‘Picture to Puncture’ (P2P): A Novel Time Metric to Enhance Outcomes in Patients Transferred for Endovascular Reperfusion in Acute Ischemic Stroke

Presenter: C.H.J. Sun

February 14, 2013

Presentation

A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke

Presenter: Chelsea S. Kidwell

February 07, 2013

Presentation

Endovascular Therapy After Intravenous t-PA vs. t-PA Alone for Stroke

Presenter: Joseph P. Broderick

February 06, 2013

Presentation

Endovascular Treatment for Acute Ischemic Stroke

Presenter: Alfonso Ciccone

February 05, 2013

Presentation TCT 2013

Vertebral Angioplasty Stenting. Are Protection Devices Useful?

Presenter: Isabelle Henry, Amira BENJELLOUN, Michel Henry

January 31, 2013

Presentation TCT 2013

Percutaneous Transluminal Angioplasty And Stenting Of Extracranial Vertebral Artery Stenoses

Presenter: Isabelle Henry, Amira BENJELLOUN, Michel Henry

January 31, 2013

Advertisement

Pharmacotherapy Alternatives During and After TAVR: Is There an Optimal Regimen?

Pathoanatomic Findings from Filtered Debris After TAVR

Comparison of Final Infarct Volumes with Endovascular Therapy vs. IV Thrombolysis for Acute Intracranial Large-Vessel Occlusions

PROTECT AF: The Mortality Effects of LAA Closure vs. Warfarin for Stroke Prophylaxis in A-fib

Angioplasty Following Carotid Stent Deployment Reduces the Risk of Restenosis and May or May Not Increase the Risk of Procedure-Related Stroke

Stroke After Primary PCI in Patients with STEMI

PFO, Subclinical Cerebrovascular Disease and Ischemic Stroke in a Population-based Cohort

Rescue Treatment of Thromboembolic Complications During Endovascular Treatment of Cerebral Aneurysms

Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation

Advanced TEE: Clinical Decision Making in Cryptogenic Stroke and Atrial Fibrillation

RESPECT: Closure of Patent Foramen Ovale (PFO) vs. Medical Therapy After Cryptogenic Stroke

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Endovascular Stroke Therapy: Tirofiban Is Associated with Risk of Fatal Intracerebral Hemorrhage and Poor Outcome

Quality-of-Life Assessment in the Randomized PROTECT AF Trial of Patients at Risk for Stroke with Nonvalvular A-fib

‘Picture to Puncture’ (P2P): A Novel Time Metric to Enhance Outcomes in Patients Transferred for Endovascular Reperfusion in Acute Ischemic Stroke

A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke

Endovascular Therapy After Intravenous t-PA vs. t-PA Alone for Stroke

Endovascular Treatment for Acute Ischemic Stroke

Vertebral Angioplasty Stenting. Are Protection Devices Useful?

Percutaneous Transluminal Angioplasty And Stenting Of Extracranial Vertebral Artery Stenoses

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content